Decrease risk bilateral acute retinal necrosis acyclovir therapy course patients unilateral acute retinal necrosis initial examination patients acyclovir patients acyclovir fellow eyes disease-free median follow-up months patients acyclovir fellow eyes disease-free median follow-up months Survival analysis fellow eyes group patients acyclovir likely disease-free fellow eyes group acyclovir years initial onset proportion fellow eyes disease-free group acyclovir group acyclovir results acyclovir treatment risk involvement fellow eye patients acute retinal necrosis 